Patient Adherence: Challenges, Myths, and Realities

  • Joel Rodriguez-Saldana


Compliance or adherence to treatment by patients is a huge worldwide problem, and the impact of poor adherence will grow as the burden of chronic disease and its comorbidities increases, and doctors persist to utilize a prescriptive approach. Lack of adherence erodes health outcomes and increases the costs of medical care. Adherence is an important modifier of the effectiveness of healthcare, and improvements enhance patients’ safety and well-being. Adherence is the result of multiple factors, including health beliefs, the personal model of disease, patients’ satisfaction with medical services, communication, and the quality of care received. In the light of the increase of diabetes, the crucial role of patients as implementers of treatment needs to be recognized, measured, and anticipated. Implementing effective adherence interventions will have a greater impact on the health of the population than modern medical therapies that patients are unwilling to take. Patients need to be supported, not blamed for their shortcomings to achieve the expected clinical outcomes; they and their families are responsible for their self-care; their efforts are decisive for the success of medical interventions.


Concordance Adherence Compliance Diabetes empowerment Motivational interviewing Clinical outcomes 


  1. 1.
    Fox R. Compliance, adherence, concordance. Circulation. 1998;97:127.CrossRefGoogle Scholar
  2. 2.
    Wild H. The economic rationale for adherence in the treatment of type 2 diabetes mellitus. Am J Manag Care. 2012;18:S43–8.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Osterberg L, Blashke T. Adherence to medication. N Engl J Med. 2005;353:487–97.PubMedCrossRefGoogle Scholar
  4. 4.
    Howie JGR. The consultation: a multi-purpose framework. In: Sheldon M, Brooke J, Rector A, editors. Decision making in general practice. London: The MacMillan Press Ltd; 1985.Google Scholar
  5. 5.
    Anderson RM, Robins LS. How do we know? Reflections of qualitative research in diabetes. Diabetes Care. 1998;21:1387–8.PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Boudes P. Drug compliance in therapeutics trials: a review. Control Clin Trials. 1998;19:257–68.PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    Haynes RB. Introduction. In: Haynes RB, et al., editors. Compliance with therapeutic regimes. Baltimore: Johns Hopkins University Press; 1976.Google Scholar
  8. 8.
    Lerner BH. From careless consumptives to recalcitrant patients: the historical construction of noncompliance. Soc Sci Med. 1997;45:1423–31.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Mohler DN, Wallin DG, Dreyfus EG. Studies in the home treatment of streptococcal disease. I. Failure of patients to take penicillin by mouth as described. N Engl J Med. 1955;252:116–8.CrossRefGoogle Scholar
  10. 10.
    Mohler DN, Wallin DG, Dreyfus EG, Bakst HJ. Studies in the home treatment of streptococcal disease. II. A comparison of the efficacy of oral administration of penicillin and intramuscular injection of benzathine penicillin in the treatment of streptococcal pharyngitis. N Engl J Med. 1956;254:45–50.PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Wood HF, Stollerman GH, Feinstein AR, Hirschfeld I, Rusoff JH, Taranta A, et al. A controlled study of three methods of prophylaxis against streptococcal infection in a population of rheumatic children. I. Streptococcal infections and recurrences of acute rheumatic fever in the first two years of the study. N Engl J Med. 1957;257:394–8.PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Feinstein AR, Wood HF, Epstein JA, Taranta A, Simpson R, Tursky E. A controlled study of three methods of prophylaxis against streptococcal infection in a population of rheumatic children. II. Results of the first three years of the study, including methods for evaluating the maintenance of oral prophylaxis. N Engl J Med. 1959;260:697–702.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Dixon WM, Stradling P. Wooton IDP: outpatient PAS therapy. Lancet. 1957;2:871–2.CrossRefGoogle Scholar
  14. 14.
    Maddock RK. Patient cooperation in taking medicines. A study involving isoniazid and aminosalicylic acid. JAMA. 1967;199:137–40.CrossRefGoogle Scholar
  15. 15.
    Vere DW. Errors of complex prescribing. Lancet. 1957;1:370–3.Google Scholar
  16. 16.
    Parsons T. The social system. Glencoe: Free Press; 1951.Google Scholar
  17. 17.
    Freidson E. Patients’ views of medical practice. New York: Sage; 1961.Google Scholar
  18. 18.
    Mechanic D. The concept of illness behavior. J Chronic Dis. 1962;15:189–94.PubMedCrossRefGoogle Scholar
  19. 19.
    Eichorn RL, Riedel DC, Morris WHM. Compliance to perceived therapeutic advice. In: Proc Purdue Farm Cardiac Seminar. Lafayette: Purdue Agricultural Station; 1959. p. 65.Google Scholar
  20. 20.
    Johannsen WJ, Hellmuth GA, Sorauf T. On accepting medical recommendations. Experiences with patients in a cardiac classification unit. Arch Environ Health. 1966;12:63–9.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Caron HS, Roth HP. Patients’ cooperation with a medical regimen. Difficulties in identifying the noncooperator. JAMA. 1968;203:120–4.CrossRefGoogle Scholar
  22. 22.
    Porter AMW. Drug defaulting in a general practice. BMJ. 1969;1:218–22.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Davis MS. Variations in patients’ compliance with doctors’ orders: analysis of congruence between survey responses and results of empirical investigations. J Med Educ. 1966;41:1037–48.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Davis MS. Variations in patients’ compliance with doctors’ advice: an empirical analysis of patterns of communication. AJPH. 1968;58:274–88.Google Scholar
  25. 25.
    Francis V, Korsch BM, Morris MJ. Gaps in doctor-patient communication. Patients’ response to medical advice. N Engl J Med. 1969;280:535–40.PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    La Greca AM. Issues in adherence with pediatric regimens. J Pediatr Psychol. 1990;15:423–36.PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Roth HP, Caron HS, His BP. Estimating a patient’s cooperation with his regimen. Am J Med Sci. 1971;262:269–73.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Weintraub M, Au WYW, Lasagna L. Compliance as a determinant of serum digoxin concentration. JAMA. 1973;224:481–5.PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Gillum RF, Barsky AJ. Patient noncompliance. JAMA. 1973;225:527.CrossRefGoogle Scholar
  30. 30.
    Gillum RF, Barsky AJ. Diagnosis and management of patient noncompliance. JAMA. 1974;228:1563–7.PubMedCrossRefGoogle Scholar
  31. 31.
    Kellaway GS, McCrae E. Non-compliance and errors of drug administration in patients discharged from acute medical wards. NZ Med J. 1975;81:508–12.Google Scholar
  32. 32.
    Baekeland F, Lundwall L. Dropping out of treatment: a critical review. Psychol Bull. 1975;82:738–83.PubMedCrossRefGoogle Scholar
  33. 33.
    Rosenstock IM. Patients’ compliance with health regimens. JAMA. 1975;234:402–3.PubMedCrossRefGoogle Scholar
  34. 34.
    Stewart MA, McWhinney IR, Buck CW. The doctor/patient relationship and its effect upon outcome. J R Coll Gen Pract. 1979;29:77–82.PubMedPubMedCentralGoogle Scholar
  35. 35.
    Mushlin AI, Appel FA. Diagnosing potential noncompliance. Arch Intern Med. 1977;137:318–21.PubMedCrossRefGoogle Scholar
  36. 36.
    Deyo RA, Inui TS. Dropouts and broken appointments. A literature review and agenda for future research. Med Care. 1980;18:1146–57.PubMedCrossRefGoogle Scholar
  37. 37.
    Greenberg RN. Overview of patient compliance with medication dosing: a literature review. Clin Ther. 1984;6:592–9.PubMedGoogle Scholar
  38. 38.
    Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Oulette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA. 1989;261:3273–7.PubMedCrossRefGoogle Scholar
  39. 39.
    Petchey R, Murphy E. Patient compliance. BMJ. 1992;305:1434–5.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Aronson JK, Hardman M. Patient compliance. BMJ. 1992;305:1009–11.PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Stephenson BJ, Rowe BH, Haynes RB, Macharia WM, Leon G. Is this patient taking the treatment as prescribed? JAMA. 1993;269:2779–81.PubMedCrossRefGoogle Scholar
  42. 42.
    Horwitz RI, Horwitz SM. Adherence to treatment and health outcomes. Arch Intern Med. 1993;153:1863–8.PubMedCrossRefGoogle Scholar
  43. 43.
    Shepard DS, Moseley TAE. Mailed versus telephoned appointment reminders to reduce broken appointments in a hospital outpatient department. Med Care. 1976;14:268–73.PubMedCrossRefGoogle Scholar
  44. 44.
    Gates SJ, Colborn K. Lowering appointment failures in a neighborhood health canter. Med Care. 1976;14:263–7.PubMedCrossRefGoogle Scholar
  45. 45.
    Macharia WM, Leon G, Rowe BH, Stephenson BJ, Haynes RB. An overview of interventions to improve compliance with appointment keeping for medical services. JAMA. 1992;267:1813–7.PubMedCrossRefGoogle Scholar
  46. 46.
    Blackwell B, Griffin B, Magill M, Bencze R. Teaching medical students about treatment compliance. J Med Educ. 1978;53:672–5.PubMedGoogle Scholar
  47. 47.
    Bond WS, Hussar DA. Detection methods and strategies for improving medication compliance. AJPH. 1991;48:1978–88.Google Scholar
  48. 48.
    Clark C, Barnard K, Cummins E, Royle P, Waugh N, Aberdeen Health Technology Assessment Group. Self-monitoring of blood glucose in type 2 diabetes: systematic review. Health Technol Assess. 2010;14(12):1–140.PubMedGoogle Scholar
  49. 49.
    McManus RJ, Wood S, Bray EP, Glasziou P, Hayen A, Heneghan C, Mant J, Padfield P, Potter JF, Hobbs FD. Self-monitoring in hypertension: a web-based survey of primary care physicians. J Hum Hypertens. 2013;28:123. [Epub ahead of print].CrossRefPubMedGoogle Scholar
  50. 50.
    Butryn ML, Phelan S, Hill JO, Wing RR. Consistent self-monitoring of weight: a key component of successful weight loss maintenance. Obesity (Silver Spring). 2007;15(12):3091–6.CrossRefGoogle Scholar
  51. 51.
    Heneghan C, Alonso-Coello P, Garcia-Alamino JM, Perera R, Meats E, Glasziou P. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet. 2006;367(9508):404–11.PubMedCrossRefGoogle Scholar
  52. 52.
    Glasziou P, Irwig L, Mant D. Monitoring in chronic disease: a rational approach. BMJ. 2005;330:644–8.PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance. A meta-analysis. Med Care. 1998;36:1138–61.PubMedCrossRefGoogle Scholar
  54. 54.
    Haynes RB, McKibbon KA, Kanani R. Systematic review of randomized trials of interventions to assist patients to follow prescriptions for medications. Lancet. 1996;348:383–6.PubMedCrossRefGoogle Scholar
  55. 55.
    Haynes RB, McKibbon KA, Brouwers MC, Oliver T. Interventions to assist patients to follow prescriptions for medications. Cochrane Libr. 1998;3:1–20.Google Scholar
  56. 56.
    McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions. Scientific review. JAMA. 2002;288:2868–79.PubMedCrossRefGoogle Scholar
  57. 57.
    Van Dulmen S, Sluijs E, van Dijk L, de Ridder D, Heerdink R, Bensing J. Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res. 2007;7:1–13.CrossRefGoogle Scholar
  58. 58.
    Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock SJ, Wines RC, Coker-Schwimmer EJ, Rosen DL, Sista P, Lohr KN. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med. 2012;157(11):785–95.PubMedCrossRefGoogle Scholar
  59. 59.
    Sackett DL. Why won’t hypertensive patients take their medicine? Can Fam Physician. 1977;23:72–4.PubMedPubMedCentralGoogle Scholar
  60. 60.
    Caldwell JR, Cobb S, Dowling MD, de Jongh D. The dropout problem in antihypertensive treatment. A pilot study of social and emotional factors influencing a patient’s ability to follow antihypertensive treatment. J Chronic Dis. 1970;22:579–92.PubMedCrossRefPubMedCentralGoogle Scholar
  61. 61.
    Carnahan JE, Nugent CA. The effects of self-monitoring by patients on the control of hypertension. Am J Med Sci. 1975;269:69–73.PubMedCrossRefPubMedCentralGoogle Scholar
  62. 62.
    Sackett DL, Haynes RB, Gibson ES, Hackett BC, Taylor DW, Roberts RS, et al. Randomized clinical trial of strategies for improving medication compliance in primary hypertension. Lancet. 1975;1:1205–7.PubMedCrossRefPubMedCentralGoogle Scholar
  63. 63.
    Haynes RB, Sackett DL, Gibson ES, Taylor DW, Hackett BC, Roberts RS, et al. Improvement of medication compliance in uncontrolled hypertension. Lancet. 1976;1:1265–8.PubMedCrossRefPubMedCentralGoogle Scholar
  64. 64.
    Finnerty FA Jr, Mattice EC, Finnerty FA 3rd. Hypertension in the inner city. Analysis of clinic dropouts. Circulation. 1973;47:73–5.PubMedCrossRefPubMedCentralGoogle Scholar
  65. 65.
    Finnerty FA. The problem of noncompliance in hypertension. Bull NY Acad Med. 1982;58:95–202.Google Scholar
  66. 66.
    Rudd P, Marton KI. Non-traditional problems of antihypertensive management. West J Med. 1979;131:179–92.PubMedPubMedCentralGoogle Scholar
  67. 67.
    Rudd P. Clinicians and patients with hypertension: unsettled issues about compliance. Am Heart J. 1995;130:572–9.PubMedCrossRefPubMedCentralGoogle Scholar
  68. 68.
    Hill MN, Miller NH, DeGeest S. ASH position paper: adherence and persistence with taking medication to control high blood pressure. J Clin Hypertens. 2010;12:757–64.CrossRefGoogle Scholar
  69. 69.
    Milchack JL, Carter BL, James PA, Ardery G. Measuring adherence to practice guidelines for the management of hypertension. An evaluation of the literature. Hypertension. 2004;44:602–8.CrossRefGoogle Scholar
  70. 70.
    Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ. 2008;336:114–117.Google Scholar
  71. 71.
    Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10:348–54.CrossRefGoogle Scholar
  72. 72.
    Korb-Savoldelli V, Gillaizeau F, Pouchot J, Lenain E, Postel-Vinay N, Plouin P-F, et al. Validation of a French version of the 8-item Morisky medication adherence scale in hypertensive adults. J Clin Hypertens. 2012;14:429–34.CrossRefGoogle Scholar
  73. 73.
    Lee GK, Wang HH, Liu KQ, Cheung Y, Morisky DE, Wong MC. Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky Medication Adherence Scale. PLoS One. 2013;8:e62775. Scholar
  74. 74.
    Lee WY, Ahn J, Kim JH, Hong YP, Hong SK, Kim YT, Lee SH, Morisky DE. Reliability and validity of a self-reported measure of medication adherence in patients with type 2 diabetes mellitus in Korea. J Int Med Res. 2013;41(4):1098–110.[Epub ahead of print].PubMedCrossRefPubMedCentralGoogle Scholar
  75. 75.
    Mülhauser I, Berger M. Patient education – evaluation of a complex intervention. Diabetologia. 2002;45:1723–33.CrossRefGoogle Scholar
  76. 76.
    Dunn SM, Turtle JR. The myth of the diabetic personality. Diabetes Care. 1981;4:640–6.PubMedCrossRefPubMedCentralGoogle Scholar
  77. 77.
    Watkins JD, Williams F, Martin DA, Hogan MD, Anderson E. A study of diabetic patients at home. AJPH. 1967;57:452–9.Google Scholar
  78. 78.
    Sulway M, Tupling H, Webb K, Harris G. New techniques for changing compliance in diabetes. Diabetes Care. 1980;3:108–11.PubMedCrossRefPubMedCentralGoogle Scholar
  79. 79.
    Anderson RM. The personal meaning of having diabetes: implications for patient behavior and education or kicking the bucket theory. Diabet Med. 1986;3:85–9.PubMedCrossRefPubMedCentralGoogle Scholar
  80. 80.
    Hampson SE, Glasgow RE, Toobert DJ. Personal models of diabetes and their relations to self-care activities. Health Psychol. 1990;9:632–46.PubMedCrossRefGoogle Scholar
  81. 81.
    Bennett-Johnson S. Methodological issues in diabetes research. Measuring adherence. Diabetes Care. 1992;15:1658–67.CrossRefGoogle Scholar
  82. 82.
    Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27:1218–24.PubMedCrossRefGoogle Scholar
  83. 83.
    Donnan PT, MacDonald TM, Morris AD. Adherence to prescribed oral hypoglycaemic medication in a population of patients with type 2 diabetes: a retrospective cohort study. Diabet Med. 2002;19:279–84.PubMedCrossRefGoogle Scholar
  84. 84.
    Hernández-Ronquillo L, Téllez-Zenteno JF, Garduño-Espinoza J, González-Aceves E. Factors associated with therapy noncompliance in type 2 diabetes patients. Salud Pública Mex. 2003;45:191–7.PubMedCrossRefGoogle Scholar
  85. 85.
    Leichter SB. Making outpatient care of diabetes more efficient: analyzing noncompliance. Clin Diabetes. 2005;23:187–90.CrossRefGoogle Scholar
  86. 86.
    Soule-Odegard P, Gray SL. Barriers to medication adherence in poorly controlled diabetes mellitus. Diabetes Educ. 2008;34:692–7.CrossRefGoogle Scholar
  87. 87.
    Schafer LC, Glasgow RE, McCaul KD, Dreher M. Adherence to IDDM. Diabetes Care. 1983;6:493–8.PubMedCrossRefPubMedCentralGoogle Scholar
  88. 88.
    Ary DV, Toobert D, Wilson W, Glasgow RE. Patient perspective on factors contributing to non-adherence to diabetes regimen. Diabetes Care. 1986;9:168–72.PubMedCrossRefPubMedCentralGoogle Scholar
  89. 89.
    Rosenstock IM. Understanding and enhancing patient compliance with diabetic regimens. Diabetes Care. 1985;8:610–6.PubMedCrossRefPubMedCentralGoogle Scholar
  90. 90.
    Bush MA. Compliance, education, and diabetes control. Mt Sinai J Med. 1987;54:221–6.PubMedPubMedCentralGoogle Scholar
  91. 91.
    Becker MH, Maiman LA. Socio-behavioral determinants of compliance with health and medical care recommendations. Med Care. 1975;13:10–24.PubMedCrossRefPubMedCentralGoogle Scholar
  92. 92.
    Kurtz SM. Adherence to diabetes regimens: empirical status and clinical applications. Diabetes Educ. 1990;16:50–9.PubMedCrossRefPubMedCentralGoogle Scholar
  93. 93.
    Haefner DP, Kirscht JP. Motivational and behavioral effects of modifying health beliefs. Public Health Rep. 1970;85:478–84.PubMedPubMedCentralCrossRefGoogle Scholar
  94. 94.
    Becker MH, Maiman LA, Kirscht JP, Haefner DP, Drachman RH. The health belief model and prediction of dietary compliance: a field experiment. J Health Soc Behav. 1977;18:348–66.PubMedCrossRefPubMedCentralGoogle Scholar
  95. 95.
    Maiman LA, Becker MH. The health belief model: origins and correlates in psychological theory. Health Educ Monogr. 1974;2:336–53.CrossRefGoogle Scholar
  96. 96.
    Rosenstock IM. Historical origins of the health belief model. Health Educ Monogr. 1974;2:328–35.CrossRefGoogle Scholar
  97. 97.
    Delamater. Improving patient adherence. Clin Diabetes. 2006;24:71–7.CrossRefGoogle Scholar
  98. 98.
    Boyer BA, Lerman C, Shipley TE, McBrearty J, Goren E. Discordance between physician and patient perceptions in the treatment of diabetes mellitus: a pilot study of the relationship to adherence and glycemic control. Diabetes Educ. 1996;22:493–9.PubMedCrossRefPubMedCentralGoogle Scholar
  99. 99.
    Du Pasquier-Fediaevsky L, Tubiana-Rufi N. Discordance between physician and adolescent assessments of adherence to treatment. Influence of HbA1c level. Diabetes Care. 1999;22:1445–9.PubMedCrossRefPubMedCentralGoogle Scholar
  100. 100.
    De Figuereido RC, Snoek FJ, Barreto SM. Do patients and physicians agree on diabetes management? A study conducted in public health centers in Brazil. Patient Educ Couns. 2013;92:107–13.CrossRefGoogle Scholar
  101. 101.
    Anderson LA. Health-care communication and selected psychosocial correlates of adherence in diabetes management. Diabetes Care. 1990;13:66–76.CrossRefGoogle Scholar
  102. 102.
    Wooldridge KL, Wallston KA, Graber AL, Brown AW, Davidson P. The relationship between health beliefs, adherence, and metabolic control in diabetes. Diabetes Educ. 1992;18:495–500.PubMedCrossRefPubMedCentralGoogle Scholar
  103. 103.
    Tillotson LM, Smith S. Locus of control, social support, and adherence to the diabetes regimen. Diabetes Educ. 1996;22:133–9.PubMedCrossRefPubMedCentralGoogle Scholar
  104. 104.
    Hauser S, Pollets D. Psychological aspects of diabetes mellitus: a critical review. Diabetes Care. 1979;2:227–32.PubMedCrossRefPubMedCentralGoogle Scholar
  105. 105.
    ISPAD Clinical Practice Consensus Guidelines Compendium 2014. Psychological care of children and adolescents with type 1 diabetes. Pediatric Diabetes. 2014;15(Suppl 20):232–44.Google Scholar
  106. 106.
    American Diabetes Association. Lifestyle management in standards of medical care in diabetes 2017. Diabetes Care. 2017;40(Suppl 1):S39–40.Google Scholar
  107. 107.
    Surwitt RS, Scovern AW, Feinglos MN. The role of behavior in diabetes care. Diabetes Care. 1982;5:337–42.CrossRefGoogle Scholar
  108. 108.
    Glasgow RE, Wilson W, McCaul KD. Regimen adherence: a problematic construct in diabetes research. Diabetes Care. 1985;8:300–1.PubMedCrossRefPubMedCentralGoogle Scholar
  109. 109.
    Glasgow RE. Psychological issues in diabetes. Diabetes Care. 1981;6:656–7.Google Scholar
  110. 110.
    Schafer LC, McCaul KD, Glasgow RE. Supportive and non-supportive family behaviors: relationships to adherence and metabolic control in persons with type 1 diabetes. Diabetes Care. 1986;9:179–85.PubMedCrossRefPubMedCentralGoogle Scholar
  111. 111.
    Wilson W, Ary DV, Biglan A, Glasgow RE, Toobert DJ, Campbell DR. Psychosocial predictors of self-care behaviors (compliance) and glycemic control in non-insulin-dependent diabetes mellitus. Diabetes Care. 1986;9:614–22.PubMedCrossRefPubMedCentralGoogle Scholar
  112. 112.
    Glasgow RE, Toobert DJ. Social environment and regimen adherence among type II diabetic patients. Diabetes Care. 1988;11:377–86.PubMedCrossRefPubMedCentralGoogle Scholar
  113. 113.
    Glasgow RE, McCaul KD, Schafer LC. Self-care behaviors and glycemic control in type 1 diabetes. J Chronic Dis. 1987;40:399–412.PubMedCrossRefPubMedCentralGoogle Scholar
  114. 114.
    Hampson SE, Glasgow RE, Foster LS. Personal models of diabetes among older adults: relationship to self-management and other variables. Diabetes Educ. 1995;21:300–7.PubMedCrossRefPubMedCentralGoogle Scholar
  115. 115.
    Glasgow RE, Hampson SE, Strycker LA, Ruggiero L. Personal-model beliefs and social-environmental barriers related to diabetes self-management. Diabetes Care. 1997;20:556–61.PubMedCrossRefPubMedCentralGoogle Scholar
  116. 116.
    Polonsky WH, Skinner TC. Perceived treatment efficacy: an overlooked opportunity in diabetes care. Clin Diabetes. 2010;28:89–92.CrossRefGoogle Scholar
  117. 117.
    Lustman PJ, Griffith LS, Clouse RE. Depression in adults with diabetes. Results of 5-yr follow-up study. Diabetes Care. 1988;11:605–12.PubMedCrossRefPubMedCentralGoogle Scholar
  118. 118.
    Lustman PJ, Griffith LS, Gavard JA, Clouse RE. Depression in adults with diabetes. Diabetes Care. 1992;11:1631–9.CrossRefGoogle Scholar
  119. 119.
    Petrak F, Bameister H, Skinner TC, Brown A, Holt RI. Depression and diabetes: treatment and health-care delivery. Lancet Diabetes Endocrinol. 2015;3:472–85.PubMedCrossRefPubMedCentralGoogle Scholar
  120. 120.
    Naicker K, Johnson JA, Skogen JC, Manuel D, Overland S, Siversten B, et al. Type 2 diabetes and comorbid symptoms of depression and anxiety: longitudinal associations with mortality risk. Diabetes Care. 2017;40:352–8.PubMedCrossRefGoogle Scholar
  121. 121.
    Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes. Impact of depressive symptoms on adherence, function and costs. Arch Intern Med. 2000;160:3278–85.PubMedCrossRefGoogle Scholar
  122. 122.
    Huang H, Russo J, Von Korff M, Ciechanowski P, Lin E, Ludman E, et al. The effect of changes in depressive symptoms on disability status in patients with diabetes. Psychosomatics. 2012;53:21–9.PubMedPubMedCentralCrossRefGoogle Scholar
  123. 123.
    Katon WJ, Rutter C, Simon G, Lin EH, Ludman E, Ciechanowski P, et al. The association of co-morbid depression with mortality in patients with type 2 diabetes. Diabetes Care. 2005;28:2668–72.PubMedCrossRefGoogle Scholar
  124. 124.
    Ciechanowski P. Diapression: an integrated model for understanding the experience of individuals with co-occurring diabetes and depression. Clin Diabetes. 2011;29:43–9.CrossRefGoogle Scholar
  125. 125.
    Egede LE, Zheng D, Simpson K. Co-morbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care. 2002;25:464–70.PubMedCrossRefPubMedCentralGoogle Scholar
  126. 126.
    Ciechanowki P, Russo J, Katon W, Simon G, Ludman E, Von Korff M, et al. Where is the patient? The association of psychosocial factors with missed primary care appointments in patients with diabetes. Gen Hosp Psychiatry. 2006;28:9–17.CrossRefGoogle Scholar
  127. 127.
    Fisher L, Gonzalez JS, Polonsky WH. The confusing tale of depression and distress in patients with diabetes: a call for greater clarity and precision. Diabet Med. 2014;31:764–72.PubMedPubMedCentralCrossRefGoogle Scholar
  128. 128.
    Fisher L, Mullan JT, Arean P, Glasgow RE, Hessler D, Masharani U. Diabetes distress and not clinical depression or depressive affect is associated with glycemic control in both cross-sectional and longitudinal analyses. Diabetes Care. 2010;33:23–8.PubMedCrossRefPubMedCentralGoogle Scholar
  129. 129.
    Gonzalez JS, Kane NS, Binko DH, Shapira A, Hoogendoorn CJ. Tangled up in blue: unraveling the links between emotional distress ans treatment adherence in type 2 diabetes. Diabetes Care. 2016;39:2182–9.PubMedPubMedCentralCrossRefGoogle Scholar
  130. 130.
    Miller WR. Behavioral treatment of problem drinkers: a comparative outcome study of three controlled drinking therapies. J Consult Clin Psychol. 1978;46:74–86.PubMedCrossRefPubMedCentralGoogle Scholar
  131. 131.
    Bandura A. Self-efficacy. The exercise of control. New York: WH Freeman and Company; 1997.Google Scholar
  132. 132.
    Rollnick S, Butler CC, McCambridge J, Kinnersley P, Elwyn G, Resnicow K. Consultations about changing behavior. BMJ. 2005;331:961–3.PubMedPubMedCentralCrossRefGoogle Scholar
  133. 133.
    Rollnick S, Butler CC, Kinnersley P, Gregory J, Mash B. Motivational interviewing. BMJ. 2010;340:1242–5.CrossRefGoogle Scholar
  134. 134.
    Miller WR, Rollnick S. Motivational interviewing. Preparing people for change. 2nd ed. New York: The Guilford Press; 2002.Google Scholar
  135. 135.
    Rollnick S, Miller WR, Butler CC. Motivational interviewing in health care: helping patients change behavior. New York: The Guilford Press; 2008.Google Scholar
  136. 136.
    Anderson RM. Patient empowerment and the traditional medical model. A case of irreconcilable differences? Diabetes Care. 1995;18:412–5.PubMedCrossRefGoogle Scholar
  137. 137.
    Anderson RM, Funnell MM. Compliance and adherence are dysfunctional concepts in diabetes care. Diabetes Educ. 2000;26:597–604.PubMedCrossRefGoogle Scholar
  138. 138.
    Anderson RM, Funnell MM, Barr PA, Dedrick RF, Davis WK. Learning to empower patients. Results of professional education program for diabetes educators. Diabetes Care. 1991;14:584–90.PubMedCrossRefGoogle Scholar
  139. 139.
    Feste C, Anderson RM. Empowerment: from philosophy to practice. Patient Educ Couns. 1995;26:139–44.PubMedCrossRefGoogle Scholar
  140. 140.
    Funnell MM, Anderson RM, Arnold MS, Barr PA, Donnelly M, Johnson PD, Taylor-Moon D, White NH. Empowerment: an idea whose time has come in diabetes education. Diabetes Educ. 1991;17:37–41.PubMedCrossRefGoogle Scholar
  141. 141.
    Anderson RM, Funnell MM. The art of empowerment. Stories and strategies for diabetes educators. Alexandria: American Diabetes Association; 2000.Google Scholar
  142. 142.
    Anderson RM, Funnell MM, Fitzgerald JT, Marrero DG. The diabetes empowerment scale: a measure of psychosocial self-efficacy. Diabetes Care. 2000;23:239–43.CrossRefGoogle Scholar
  143. 143.
    Anderson RM, Funnell MM, Aikens JE, Krein SL, Fitzgerald JT, Nwankwo R, Tannas CL, Tang TS. Evaluating the efficacy of an empowerment-based Self-management consultant intervention: results of a two-year randomized controlled trial. Ther Patient Educ. 2009;1:3–11.PubMedPubMedCentralCrossRefGoogle Scholar
  144. 144.
    Anderson RM, Funnell MM. Patient empowerment: myths and misconceptions. Patient Educ Couns. 2010;79:277–82.PubMedCrossRefPubMedCentralGoogle Scholar
  145. 145.
    Luftey KE, Ketchman JD. Patient and provider assessments of adherence and the sources of disparities: evidence from diabetes care. Health Serv Res. 2005;40:1803–17.CrossRefGoogle Scholar
  146. 146.
    Littenberg B, MacLean CD, Hurowitz L. The use of adherence aids by adults with diabetes: a cross sectional survey. BMC Fam Pract. 2006;7:1–5.PubMedPubMedCentralCrossRefGoogle Scholar
  147. 147.
    Puder JJ, Keller U. Quality of diabetes care: problem of patient or doctor adherence? Swiss Med Wkly. 2003;133:530–4.PubMedPubMedCentralGoogle Scholar
  148. 148.
    Samuels TA, Bolen S, Yeh HC, Abuid M, Marinoupoulos SS, Weiner JP, et al. Missed opportunities in diabetes management: a longitudinal assessment of factors associated with sub-optimal quality. J Gen Intern Med. 2008;23:1770–7.PubMedPubMedCentralCrossRefGoogle Scholar
  149. 149.
    Schmittdiel JA, Uratsu CS, Karter AJ, Heisler M, Subramanian U, Mangione CM, Selby JV. Why don’t patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med. 2008;23:588–94.PubMedPubMedCentralCrossRefGoogle Scholar
  150. 150.
    Van Bruggen R, Gorter K, Stolk RP, Zuithoff P, Klungel OH, Rutten GEHM. Refill adherence and polypharmacy among patients with type 2 diabetes in general practice. Pharmacoepidemiology Drug Saf. 2009;18:983–91.CrossRefGoogle Scholar
  151. 151.
    Miller TA, DiMatteo MR. Importance of family/social support and impact on adherence to diabetic therapy. Diabetes Metab Syndr Obes. 2013;6:421–6.PubMedPubMedCentralCrossRefGoogle Scholar
  152. 152.
    Del Canale S, Louis DZ, Maio V, Wang X, Rossi G, Hojat M, Gonella JS. The relationship between physician empathy and disease complications: an empirical study of primary care physicians and their diabetic patients in Parma, Italy. Acad Med. 2012;87:1243–9.PubMedCrossRefGoogle Scholar
  153. 153.
    Beaser RS, Brown JA. Preventive intervention in diabetes: a new model for continuing medical education. Am J Prev Med. 2013;44:S394–9.PubMedCrossRefGoogle Scholar
  154. 154.
    Iuga AO, McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy. 2014;4:35–44.Google Scholar
  155. 155.
    Stolpe S, Kroes MA, Webb N, Wisniewski T. A systematic review of insulin adherence measures in patients with diabetes. J Manag Care Spec Pharm. 2016;22:1224–46.PubMedGoogle Scholar
  156. 156.
    Yeaw J, Benner JS, Walt JG, Sian S, Smith DB. Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm. 2009;15:728–40.PubMedGoogle Scholar
  157. 157.
    Fischer MA, Stedman MR, Lii J, Vogeli C, Shrank WH, Brookhart MA, et al. Primary medication non-adherence: analysis of 195,930 prescriptions. J Gen Int Med. 2010;25:284–90.CrossRefGoogle Scholar
  158. 158.
    Koro CE, Chabra P, Stender M, Spain CV, Allen JK, Krzywy HJ. Treatment utilization of GLP-1 Agonists and DPP-4 Inhibitors among Type 2 Diabetics in a U.S. commercially insured population 2005–2011. Diabetes. 2013;62:A365–438.CrossRefGoogle Scholar
  159. 159.
    Alfian SD, Sukandar H, Lestari K, Abdulah R. Medication adherence contributes to an improved quality of life in type 2 diabetes mellitus patients: a cross-sectional study. Diabetes Ther. 2016;7:755–64.PubMedPubMedCentralCrossRefGoogle Scholar
  160. 160.
    Al-Keliani MS, Almomani BA, Al-Sawalha NA, Shhabat BA. Self-monitoring of blood glucose among patients in Jordan: perception, adherence and influential factors. Diabetes Res Clin Pract. 2017;126:79–85.CrossRefGoogle Scholar
  161. 161.
    He X, Chen L, Wang K, Wu H, Wu J. Insulin adherence among Chinese patients with type 2 diabetes: a retrospective database analysis. Patient Prefer Adherence. 2017;11:237–45.PubMedPubMedCentralCrossRefGoogle Scholar
  162. 162.
    Lin J, Lingohr-Smith M, Fan T. Real-world medication persistence and outcomes associated with basal insulin and glucagon-like peptide I receptor agonist free-dose combination therapy in patients with type 2 diabetes in the US. Clinicoecon Outcomes Res. 2017;9:19–29.PubMedCrossRefGoogle Scholar
  163. 163.
    Flory J, Gerhard T, Stempniewicz N, Keating S, Rowan CG. Comparative adherence to diabetes drugs: an analysis of electronic health records and claims data. Diabetes Obes Metab. 2017;19:1184–7.PubMedCrossRefGoogle Scholar
  164. 164.
    Birnbaum Y, Ye Y, Bajaj M. Type 2 and cardiovascular disease: a metabolic overview of recent clinical trials. J Diabetes Complicat. 2017;31:291–4.PubMedCrossRefGoogle Scholar
  165. 165.
    Kosiborod M. Following the LEADER – why this and other recent trials signal a major paradigm in the management of type 2 diabetes. J Diabetes Complicat. 2017;31:517–9.PubMedCrossRefGoogle Scholar
  166. 166.
    Ingelfinger FJ. Arrogance. N Engl J Med. 1980;303:1507–11.PubMedCrossRefGoogle Scholar
  167. 167.
    Romano PE. Semantics: compliance is a better term than cooperation. Arch Ophtalmol. 1987;105:314–5.CrossRefGoogle Scholar
  168. 168.
    Steiner JF, Earnest MA. The language of medication-taking. Ann Intern Med. 2000;132:926–30.PubMedCrossRefGoogle Scholar
  169. 169.
    Luftey KE, Wishner WJ. Beyond “compliance is adherence”. Improving the prospect of diabetes care. Diabetes Care. 1999;22:635–9.CrossRefGoogle Scholar
  170. 170.
    Glasgow RE, Anderson RM. In diabetes care, moving from compliance to adherence is not enough. Something entirely different is needed. Diabetes Care. 1999;22:2090–2.PubMedCrossRefGoogle Scholar
  171. 171.
    Dracup KA, Meleis AI. Compliance: an interactionist approach. Nurs Res. 1982;31:31–6.PubMedCrossRefGoogle Scholar
  172. 172.
    Meichenbaum D, Turk DC. Facilitating treatment adherence: a practitioner’s guidebook. New York: Plenum Publishing Corp; 1987.CrossRefGoogle Scholar
  173. 173.
    Wright EC. Non-compliance – or how many aunts has Matilda? Lancet. 1993;342:909–13.PubMedCrossRefGoogle Scholar
  174. 174.
    Urquart J. Patient non-compliance with drug regimens: measurement, clinical correlates, economic impact. Eur Heart J. 1996;17:8–15.CrossRefGoogle Scholar
  175. 175.
    Houston-Miller N, Hill M, Kottke T, Ockene IS. The multilevel challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation. 1997;95:1085–90.CrossRefGoogle Scholar
  176. 176.
    World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: WHO; 2003. p. p3.Google Scholar
  177. 177.
    Balkrishnan R. The importance of medication adherence in improving chronic disease related outcomes: what we know and what we need to further know. Med Care. 2005;43:517–20.PubMedCrossRefPubMedCentralGoogle Scholar
  178. 178.
    Steiner JF. Rethinking adherence. Ann Intern Med. 2012;157:580–5.PubMedCrossRefPubMedCentralGoogle Scholar
  179. 179.
    Raebel MA, Ellis JL, Carroll NM, Bayliss EA, McGinnis B, Schroeder EB, et al. Characteristics of patients with primary non-adherence to medications for hypertension, diabetes and lipid disorders. J Gen Intern Med. 2011;27:57–64.PubMedPubMedCentralCrossRefGoogle Scholar
  180. 180.
    Neiman AB, Ruppar T, Garber L, Weidle PJ, Hong Y, George MG, et al. CDC grand rounds: improving medication adherence for chronic disease management – innovation and opportunities. Morb Mortal Wkly Rep. 2017;66:1248–51.CrossRefGoogle Scholar
  181. 181.
    National Community Pharmacist Association. Medication adherence in America: a National Report 2013. Accessed 10 July 2018 at
  182. 182.
    Butler C, Rollnick S, Stott N. The practitioner, the patient and resistance to change: recent ideas on compliance. Can Med Assoc J. 1996;154:1357–62.Google Scholar
  183. 183.
    Glasgow RE, Emont S, Miller DC. Assessing delivery of the five “As” for patient-centered counseling. Health Promot Int. 2006;21:245–55.PubMedCrossRefPubMedCentralGoogle Scholar
  184. 184.
    Blackwell B. Patient compliance. N Engl J Med. 1973;289:249–52.PubMedCrossRefGoogle Scholar
  185. 185.
    LaFleur J, Nelson RE, Sauer BC, Nebeker JR. Overestimation of the effects of adherence outcomes: a case study in healthy user bias and hypertension. Heart. 2011;97:1862–9.PubMedCrossRefPubMedCentralGoogle Scholar
  186. 186.
    Brown MT, Bussell J, Dutta S, Davis K, Strong S, Mathew S. Medication adherence: truth and consequences. Am J Med Sci. 2016;351:387–99.PubMedCrossRefPubMedCentralGoogle Scholar
  187. 187.
    Beach MC, Sugarman J, Johnson RL, Arbelaez JJ, Duggan PS, Cooper LA. Do patients treated with dignity report higher satisfaction, adherence, and receipt of preventive care? Ann Fam Med. 2005;3:331–8.PubMedPubMedCentralCrossRefGoogle Scholar
  188. 188.
    Campbell SM, Roland MO. Why people consult the doctor? Fam Pract. 1996;13:75–83.PubMedCrossRefPubMedCentralGoogle Scholar
  189. 189.
    Fiddes PJ, Brooks PM, Komesaroff P. The patient is the teacher: ambulatory patient-centered student-based inter-professional education where the patient is the teacher who improves patient care outcomes. Int Med J. 2013;43:747–50.CrossRefGoogle Scholar
  190. 190.
    Pallarés-Carratalá V, Pérez RP. Non-compliance and therapeutic inertia: two unanswered questions in clinical practice. Curr Med Res Opin. 2014;30:839–40.PubMedCrossRefPubMedCentralGoogle Scholar
  191. 191.
    Hearnshaw H, Lindenmeyer A. What do we mean by adherence to treatment and advice for living with diabetes? A review of the literature on definitions and measurements. Diabet Med. 2006;23(7):720–8.PubMedCrossRefPubMedCentralGoogle Scholar
  192. 192.
    Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016;10:1299–307.PubMedPubMedCentralCrossRefGoogle Scholar
  193. 193.
    Krass I, Schieback P, Dhippayom T. Adherence to diabetes medication: a systematic review. Diabet Med. 2015;32:725–37.PubMedCrossRefPubMedCentralGoogle Scholar
  194. 194.
    Brown JB, Harris SB, Webster-Bogaert S, Wetmore S, Faulds C, Stewart M. The role of patient, physician and systemic factors in the management of type 2 diabetes mellitus. Fam Pract. 2002;19:344–9.PubMedCrossRefPubMedCentralGoogle Scholar
  195. 195.
    Jha AK, Aubert RE, Yao J, Teagarden JR, Epstein RS. Greater adherence to diabetes drugs is linked to less hospital use and could save nearly $5 billion annually. Health Aff. 2012;31:1836–44.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Joel Rodriguez-Saldana
    • 1
  1. 1.Multidisciplinary Centre of DiabetesMexico CityMexico

Personalised recommendations